Cardiol Therapeutics Inc - Ordinary Shares - Class A
CRDL
Get informed when a big investor buys or sells
+ FollowMarket Cap$139.48M
Close$
$0.17
85.9% downside
Current Fair Value
85.9% downsideOvervalued by 85.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $139.48 Million |
|---|---|
| Enterprise Value | $111.85 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.39 |
| Beta | 0.51 |
| Outstanding Shares | 108,987,584 |
Return
| Return on Equity | -149.91% |
|---|---|
| Return on Assets | -115.53% |
| Return on Invested Capital | -145.44% |
Valuation & Multiples
| P/E Ratio | -4.32 |
|---|---|
| PEG | -13.99 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.16 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.17%▼ 27.63% |
|---|---|
| Total Invested | $204,213▼ 99.46% |
| Investors Holding | 5▼ 44.00% |
ESG Score
No data